Dublin, March 13, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Interventional Cardiology Global Market - Forecast to 2023" report to their offering.
The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023.
Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.
The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of Cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.
The interventional cardiology global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.
Some of the key players of the interventional cardiology market are Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.).
Factors Influencing Market
Drivers and Opportunities
- Increase in Prevalence of Cardiovascular Disorders Due to Rise in Aging Population
- Increasing Number of Interventional Procedures
- Rise in the Number of Clinical Studies Performed
- Increasing Prevalence of Lifestyle Diseases
- Technology Advancements and Growing Healthcare Budgetary Allocation
- Growth in Emerging Countries
- Increase in Patient Awareness for Minimal Invasive Surgeries
Restraints and Threats
- Stringent Regulatory Requirements With High Cost of Development
- Lack of Skilled and Trained Professionals
- Availability of Alternatives Products and Procedures
- Reimbursement Issues in Emerging Countries
Companies Mentioned
- Abbott Laboratories
- Abiomed, Inc.
- Acandis
- Accellent Inc.
- Acist Medical Systems
- Admedes Schuessler Gmbh
- Alpha Medical
- Amg International Gmbh
- Angiodynamics, Inc.
- Angioslide, Inc.
- APC Cardiovascular, Ltd.
- Applied Medical
- Argon Medical Devices
- Arravasc, Ltd.
- Articure Inc.
- Asahi Intec
- Ash Access Technology, Inc.
- Asid Bonz Gmbh
- Avinger, Inc.
- B. Braun Melsungen AG
- Balton Sp. Z O.O.
- Baylis Medical
- Bioabsorbable Therapeutics, Inc.
- Biomerics
- Biophan Technologies, Inc.
- Bioring SA
- Biosensors International Group, Ltd.
- Bioteque Corporation
- Biotronik Gmbh & Co.
- Bioventrix
- Blue Medical Devices BV
- Bolton Medical
- Boston Scientific Corporation
- Braile Biomedica
- Brosmed Medical Co. Ltd
- Burpee Materials Technology L.L.C.
- C. R. Bard, Inc.
- Cappella Inc.
- Capture Vascular System
- Cardiatis
- Cardio Med
- Cardiofocus, Inc.
- Cardionovum Gmbh
- Cardiovascular Systems, Inc.
- Cardiva Medical, Inc.
- Cathrx Ltd.
- CID SRL
- Claret Medical, Inc.
- Clearstream Technologies Group Plc
- Concentric Medical
- Control Medical Technology
- Cook Medical
- Cornova, Inc.
- Cradinal Health
- Devax, Inc.
- Diros Technology
- Disa Vascular (Pty) Ltd.
- Dispomedica Gmbh
- Edwards Lifesciences
- Elixir Medical Corporation
- Endocor Gmbh
- Endologix Incorporated
- Endospan
- Eucatech AG
- Eurocor Gmbh
- FCare Systems
- Fortimedix B.V
- Fuji Systems Corporation
- Getinge Group
- Goodman Co., Ltd.
- Hansen Medical
- Heartflow
- Hexacath
- Iberhospitex S.A
- Icon Medical Corp.
- ICU Medicals
- Infraredx, Inc.
- Insitu Technologies Inc.
- Inspiremed Ltd.
- ITGI Medical Ltd.
- Ivascular
- Johnson and Johnson (Biosense Webster)
- Jotec Gmbh
- Le Maitre Vascular, Inc.
- Lepu Medical
- Lifetech Scientific Corporation
- Lombard Medical Technologies, Plc.
- Medinol Ltd.
- Medtronic, Plc
- Meril Life Sciences Pvt. Ltd.
- Merit Medical Systems, Inc.
- Miami Cardiovascular Innovations Corp.
- Micell Technologies, Inc.
- Microport Scientific Corporation
- Millar Instruments, Inc.
- Minvasys
- Mitragen
- MIV Therapeutics Inc.
- Nano Endoluminal S.A.
- Natec Medical
- Oct Medical Imaging, Inc.
- Opsens Medical
- Optimed Medizinische Instrumente Gmbh
- Optiray Medizintechnik Gmbh
- Opto Circuits India Limited
- Orbusneich
- Penumbra, Inc.
- PFM Medical AG
- Philips
- Polymerex Medical Corp.
- Procyrion, Inc.
- QT Vascular
- Relisys Medical Devices Limited
- Reva Medical, Inc.
- Rex Medical
- Sahajanand Medical Technologies Pvt. Ltd.
- Sichuan Jinjiang Electronic Science and Technology Co., Ltd
- Siemens Healthcare
- St. George Medical
- Stentys S.A.S.
- Straub Medical
- Stryker Corporation
- Surgical Specialties Corporation
- Teleflex, Inc.
- Terumo Corporation
- Transcatheter Technologies Gmbh
- Translumina Gmbh
- Tryton Medical, Inc.
- Vactronix Scientific Inc.
- Vascular Concepts
- Vascular Solutions Inc.
- Volcano Corporation (Philips)
- W.L. Gore& Associates
- Xtent, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/5vrf9s/interventional